Literature DB >> 23151138

The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.

Zheng Ying1, Hongfeng Wang, Guanghui Wang.   

Abstract

Neurodegenerative diseases are severe disorders characterized by progressive neurodegeneration in specific brain regions. The ubiquitin-proteasome system (UPS) is closely linked to neurodegenerative disease. In most cases, UPS impairment and dysregulation of the UPS components are frequently observed. Moreover, toxin-induced neurodegeneration produces neuronal cell death accompanied by decreased UPS function. These studies suggest an involvement of the UPS in these diseases. In this review, we summarize the changes to UPS components in neurodegenerative diseases and the association between the UPS and disease pathology. Dysfunction of the UPS results in the abnormal accumulation of proteins; thus, the UPS plays a critical role in disease pathogenesis. Drugs targeting specific components of the UPS may provide promising strategies for disease treatment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23151138     DOI: 10.2174/1381612811319180013

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  13 in total

1.  Bcl-2 Decreases the Affinity of SQSTM1/p62 to Poly-Ubiquitin Chains and Suppresses the Aggregation of Misfolded Protein in Neurodegenerative Disease.

Authors:  Liang Zhou; Hongfeng Wang; Haigang Ren; Qingsong Hu; Zheng Ying; Guanghui Wang
Journal:  Mol Neurobiol       Date:  2014-10-14       Impact factor: 5.590

2.  Differential Contributions of Alcohol and the Nicotine-Derived Nitrosamine Ketone (NNK) to Insulin and Insulin-Like Growth Factor Resistance in the Adolescent Rat Brain.

Authors:  Ming Tong; Rosa Yu; Chetram Deochand; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2015-09-15       Impact factor: 2.826

3.  Using the Ubiquitin-modified Proteome to Monitor Distinct and Spatially Restricted Protein Homeostasis Dysfunction.

Authors:  Joshua M Gendron; Kristofor Webb; Bing Yang; Lisa Rising; Nathan Zuzow; Eric J Bennett
Journal:  Mol Cell Proteomics       Date:  2016-05-16       Impact factor: 5.911

Review 4.  Monitoring autophagy in the treatment of protein aggregate diseases: steps toward identifying autophagic biomarkers.

Authors:  Conrad C Weihl
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

Review 5.  Trial Watch: Proteasomal inhibitors for anticancer therapy.

Authors:  Florine Obrist; Gwenola Manic; Guido Kroemer; Ilio Vitale; Lorenzo Galluzzi
Journal:  Mol Cell Oncol       Date:  2014-12-01

6.  Whole genome sequence analyses of brain imaging measures in the Framingham Study.

Authors:  Chloé Sarnowski; Claudia L Satizabal; Charles DeCarli; Achilleas N Pitsillides; L Adrienne Cupples; Ramachandran S Vasan; James G Wilson; Joshua C Bis; Myriam Fornage; Alexa S Beiser; Anita L DeStefano; Josée Dupuis; Sudha Seshadri
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

7.  Potential Co-Factor Role of Tobacco Specific Nitrosamine Exposures in the Pathogenesis of Fetal Alcohol Spectrum Disorder.

Authors:  Valerie Zabala; Elizabeth Silbermann; Edward Re; Tomas Andreani; Ming Tong; Teresa Ramirez; Fusun Gundogan; Suzanne M de la Monte
Journal:  Gynecol Obstet Res       Date:  2016-03-15

Review 8.  Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?

Authors:  Cyril Laurent; Luc Buée; David Blum
Journal:  Biomed J       Date:  2018-03-20       Impact factor: 4.910

Review 9.  The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.

Authors:  Kundlik Gadhave; Nityanand Bolshette; Ashutosh Ahire; Rohit Pardeshi; Krishan Thakur; Cristiana Trandafir; Alexandru Istrate; Sahabuddin Ahmed; Mangala Lahkar; Dafin F Muresanu; Maria Balea
Journal:  J Cell Mol Med       Date:  2016-03-29       Impact factor: 5.310

Review 10.  A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease.

Authors:  Rubayat Islam Khan; Saif Shahriar Rahman Nirzhor; Barnaly Rashid
Journal:  Brain Sci       Date:  2018-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.